Showing results (11-20 of 62) with videos related to

Sort By:
Pageof 7
Chembiochem : a European Journal of Chemical Biology|April 8, 2009
A pan-specific inhibitor of the polo-box domains of polo-like kinases arrests cancer cells in mitosisWolfgang Reindl, Juping Yuan, Andrea Krämer, et al.
Oncotarget|January 18, 2012
Mitotic centromere-associated kinesin (MCAK): a potential cancer drug targetMourad Sanhaji, Claire T Friel, Linda Wordeman, et al.
Oncotarget|October 8, 2016
Impact of Polo-like kinase 1 inhibitors on human adipose tissue-derived mesenchymal stem cellsAndreas Ritter, Alexandra Friemel, Nina-Naomi Kreis, et al.
Critical Reviews in Biochemistry and Molecular Biology|May 6, 2016
Molecular insight into the regulation and function of MCAKAndreas Ritter, Nina-Naomi Kreis, Frank Louwen, et al.
Oncotarget|August 30, 2012
A lesson for cancer research: placental microarray gene analysis in preeclampsiaFrank Louwen, Cornelia Muschol-Steinmetz, Joscha Reinhard, et al.
Oncotarget|December 16, 2014
The activity regulation of the mitotic centromere-associated kinesin by Polo-like kinase 1Andreas Ritter, Mourad Sanhaji, Kerstin Steinhäuser, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|July 11, 2012
The Effects of Clinical Hypnosis versus Neurolinguistic Programming (NLP) before External Cephalic Version (ECV): A Prospective Off-Centre Randomised, Double-Blind, Controlled TrialJoscha Reinhard, Swati Peiffer, Nicole Sänger, et al.
Cell Cycle (Georgetown, Tex.)|April 12, 2013
Polo-like kinase 1 inhibitors, mitotic stress and the tumor suppressor p53Mourad Sanhaji, Frank Louwen, Brigitte Zimmer, et al.
Cell Cycle (Georgetown, Tex.)|January 21, 2012
p53 is not directly relevant to the response of Polo-like kinase 1 inhibitorsMourad Sanhaji, Nina-Naomi Kreis, Brigitte Zimmer, et al.
Human Reproduction Update|May 31, 2022
BCL6, a key oncogene, in the placenta, pre-eclampsia and endometriosisFrank Louwen, Nina-Naomi Kreis, Andreas Ritter, et al.
Pageof 7